Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Total Liabilities: 2010-2020

Historic Total Liabilities for Neurocrine Biosciences (NBIX) over the last 11 years, with Dec 2020 value amounting to $608.5 million.

  • Neurocrine Biosciences' Total Liabilities fell 3.87% to $671.3 million in Q3 2021 from the same period last year, while for Sep 2021 it was $671.3 million, marking a year-over-year decrease of 3.87%. This contributed to the annual value of $608.5 million for FY2020, which is 9.06% down from last year.
  • Neurocrine Biosciences' Total Liabilities amounted to $608.5 million in FY2020, which was down 9.06% from $669.1 million recorded in FY2019.
  • Over the past 5 years, Neurocrine Biosciences' Total Liabilities peaked at $669.1 million during FY2019, and registered a low of $50.2 million during FY2016.
  • Its 3-year average for Total Liabilities is $596.7 million, with a median of $608.5 million in 2020.
  • In the last 5 years, Neurocrine Biosciences' Total Liabilities spiked by 787.20% in 2017 and then declined by 9.06% in 2020.
  • Neurocrine Biosciences' Total Liabilities (Yearly) stood at $50.2 million in 2016, then spiked by 787.20% to $445.5 million in 2017, then climbed by 15.03% to $512.4 million in 2018, then surged by 30.59% to $669.1 million in 2019, then dropped by 9.06% to $608.5 million in 2020.